Big Pharma's Hidden Business Model and How Your Company Funds It
Harvard Business Review
SEPTEMBER 12, 2012
Since companies test their own products—an obvious conflict of interest—they naturally design clinical trials to maximize evidence that they are beneficial and minimize evidence they are harmful. See The Risks of Prescription Drugs (Columbia 2010). These cost employers even more in hidden ways.
Let's personalize your content